Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Agostino Riva

A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis ⬇️

scientific article published on December 1, 1997

A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients

scientific article

A novel sensitive assay to define immune status using short-term peripheral blood derived cell culture and dual-color flow cytometry ⬇️

scientific article published on May 1, 1998

Bictegravir/emtricitabine/tenofovir alafenamide-induced acute pancreatitis: a case report

scientific article published on 21 July 2020

Broad betacoronavirus neutralization by a stem helix–specific human antibody

scientific article

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

scientific article

Clinical and genetic determinants of nevirapine plasma trough concentration.

scientific article published on 5 June 2018

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy

article

Clinical features and outcomes of HIV patients with coronavirus disease 2019

scientific article published on 14 May 2020

Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers: a randomized, open-label, 2-period, single-dose, crossover phase 1 study

scientific article published on February 2015

Does lopinavir really inhibit SARS-CoV-2?

scientific article published on 10 May 2020

Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?

scientific article published on 23 December 2016

Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference

scientific article published on 3 March 2017

Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis

scientific article

Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics

scientific article published on 25 April 2013

Liver Injury After Occasional Energy Drink Use in a Patient Living With HIV and Diabetes

scientific article published on 18 October 2019

Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events

scientific article (publication date: 2013)

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

scientific article published on 16 September 2020

Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?

scientific article

Orlistat: weight lost at cost of HIV rebound

scientific article published on 5 March 2016

PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response

scientific article published in 2021

Pharmacogenetics-based optimisation of atazanavir treatment: potential role of new genetic predictors

scientific article published in May 2017

Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients

scientific article published on 3 October 2014

Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienne

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies

scientific article

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

scientific article

Severe Hyperbilirubinemia in an HIV-HCV-Coinfected Patient Starting the 3D Regimen That Resolved After TDM-Guided Atazanavir Dose Reduction

scientific article

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01

scientific article published on 22 October 2019

Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriers

scientific article published on 02 June 2012

Systemic lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and review of the literature ⬇️

scientific article published on 07 May 2013

The human IL-7 receptor gene: Deletions, polymorphisms and mutations ⬇️

scientific article published on March 17, 2012

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

scientific article

Paulina is supported by:

About Paulina

Help